What's on the web on your pursuit, hobbies, interests and worries

HunterSyndrome news

UNC Pediatrics Delivers Gene Therapy to Hunter Syndrome Patient


Rare Disease Report - Mar 22, 2018
A 40-year old patient at the University of North Carolina's (UNC) Clinical and Translational Research Center (CTRC) was treated with SB-913 this week. The investigational genome editing therapy is intended for individuals with mucopolysaccharidosis ...
 

Investigational genome editing therapy in clinical trial for Hunter syndrome


Medical Xpress - Mar 22, 2018
Hunter syndrome is a rare progressive disorder that primarily affects males and is caused by mutations in the gene encoding the iduronate-2-sulfatase (IDS) enzyme. Individuals with Hunter syndrome can have a wide spectrum of clinical involvement from ...
 

Mucopolysaccharidosis II (MPS II)/ Hunter Syndrome Market Latest ...


Pharmaceuticals News - Apr 13, 2018
Mucopolysaccharidosis II (MPS II)/ Hunter syndrome is a congenital condition which leads to complications in carbohydrate metabolism. The first individual with X-linked Mucopolysaccharidosis (MPS) was first reported in 1917 by a clinician named Hunter ...
 

Hunter Syndrome - premium items on eBay

>> Go to all great Hunter Syndrome deals on eBay


Hunter Syndrome pictures on the web

>> Show

Hunter Syndrome videos

What Is Hunter Syndrome?


For more information, visit: http://projectalive.org Video Produced by Caravan: http://wearecaravan.tv.
 

What is Hunter Syndrome?


Hunter syndrome (MPS II) is a hereditary disease. It is a lysosomal storage disorder caused by the deficiency or absence of the lysosomal enzyme iduronate-2-sulfatase. The deficiency or absence...
 

What is Hunter Syndrome?


Parents Chris and Melissa and The Doctors are joined by Hunter Syndrome expert Dr. Patricia Dickson to talk about this rare condition. And their son Case joins the stage to receive some very...
 

Key Features of Hunter syndrome: MPS II Global Webinar - Part 1


Hunter syndrome (MPS II) is a lysosomal storage disorder. The disease is caused by a genetic defect but is also an active process and so the signs and symptoms begin before birth but continue...
 

First human clinical trial for Hunter syndrome underway at Emory


A first-in-man clinical trial, testing a newly developed drug for a rare genetic condition called mucopolysaccharidosis type II (MPS II) or Hunter syndrome, is underway at Emory University.